Using genomics and transcriptomics to characterize the immune microenvironment in DLBCL |
10/18/2021 - 12:00pm to 1:00pm |
Targetable Genetic Bases of Immune Evasion in Lymphoma |
10/25/2021 - 12:00pm to 1:00pm |
Grand Rounds: Therapeutic Decision-Making in Metastatic Renal Cell and Prostate Cancers |
11/01/2021 - 12:00pm to 1:00pm |
When DNA Repair Causes DNA Damage: Base Excision Repair Protein Dysregulation as a Driver of Genomic Instability, Cellular Transformation and Chemotherapy Response |
11/08/2021 - 12:00pm to 1:00pm |
Identification of distinct immune signatures in malignant pleural mesothelioma |
11/22/2021 - 12:00pm to 1:00pm |
Patient-Reported Outcomes (PROs) and Quality of Life in Lymphoid Malignancies |
11/29/2021 - 12:00pm to 1:00pm |
Racial Disparities in Post-Surgical Pain Outcomes Among Women with Early-Stage Breast Cancer |
12/20/2021 - 12:00pm to 1:00pm |
Mechanism of Disease Progression in Plasmacell Disorders |
01/03/2022 - 12:00pm to 1:00pm |
Novel Immunotherapeutic Strategies for Lung Cancer |
01/10/2022 - 12:00pm to 1:00pm |
New Frontiers in Head and Neck Cancer: Expanding the application of Immunotherapy and Biomarkers |
01/24/2022 - 12:00pm to 1:00pm |